ProfileGDS5822 / ILMN_2813284
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 77% 81% 79% 80% 79% 80% 79% 80% 76% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 195.877
GSM1276600PDAC Late Ablation Control 2162.881
GSM1276601PDAC Late Ablation Control 3184.179
GSM1276602PDAC Late Ablation 1135.280
GSM1276603PDAC Late Ablation 2142.479
GSM1276604PDAC Late Ablation 3149.680
GSM1303940PDAC Late Ablation_anti-CTLA4 1115.779
GSM1303941PDAC Late Ablation_anti-CTLA4 2176.680
GSM1303942PDAC Late Ablation_anti-CTLA4 3128.876